Moderna, Inc. (MRNA)
225.00
+28.00
(+14.21%)
USD |
NASDAQ |
Oct 09, 16:00
223.55
-1.45
(-0.64%)
After-Hours: 06:08
Moderna Free Cash Flow (Quarterly) : -563.00M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -563.00M |
| March 31, 2026 | -692.00M |
| December 31, 2025 | 891.00M |
| September 30, 2025 | -880.00M |
| June 30, 2025 | -922.00M |
| March 31, 2025 | -1.164B |
| December 31, 2024 | 303.00M |
| September 30, 2024 | -1.717B |
| June 30, 2024 | -1.456B |
| March 31, 2024 | -1.185B |
| December 31, 2023 | 402.00M |
| September 30, 2023 | -1.74B |
| June 30, 2023 | -1.149B |
| March 31, 2023 | -1.338B |
| December 31, 2022 | 1.57B |
| September 30, 2022 | 163.00M |
| June 30, 2022 | 217.00M |
| March 31, 2022 | 2.631B |
| Date | Value |
|---|---|
| December 31, 2021 | 3.19B |
| September 30, 2021 | 3.177B |
| June 30, 2021 | 4.033B |
| March 31, 2021 | 2.936B |
| December 31, 2020 | 1.241B |
| September 30, 2020 | 873.46M |
| June 30, 2020 | -42.51M |
| March 31, 2020 | -112.41M |
| December 31, 2019 | -104.71M |
| September 30, 2019 | -113.80M |
| June 30, 2019 | -119.17M |
| March 31, 2019 | -151.86M |
| December 31, 2018 | -104.66M |
| September 30, 2018 | -108.10M |
| June 30, 2018 | -80.58M |
| March 31, 2018 | -143.29M |
| December 31, 2017 | -114.89M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Vaxcyte, Inc. | -237.04M |
| Revolution Medicines, Inc. | -389.60M |
| Sarepta Therapeutics, Inc. | 196.52M |
| Twist Bioscience Corp. | -8.648M |
| BioNTech SE | -52.17M |